Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Return on Assets (2016 - 2025)

Historic Return on Assets for Pharma-Bio Serv (PBSV) over the last 15 years, with Q4 2025 value amounting to 0.01%.

  • Pharma-Bio Serv's Return on Assets rose 400.0% to 0.01% in Q4 2025 from the same period last year, while for Oct 2025 it was 0.01%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.01% for FY2025, which is 400.0% up from last year.
  • Pharma-Bio Serv's Return on Assets amounted to 0.01% in Q4 2025, which was up 400.0% from 0.01% recorded in Q3 2025.
  • In the past 5 years, Pharma-Bio Serv's Return on Assets registered a high of 0.1% during Q3 2021, and its lowest value of 0.2% during Q3 2022.
  • Moreover, its 5-year median value for Return on Assets was 0.0% (2025), whereas its average is 0.0%.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -3000bps in 2022, then soared by 2800bps in 2023.
  • Over the past 5 years, Pharma-Bio Serv's Return on Assets (Quarter) stood at 0.08% in 2021, then soared by 162bps to 0.05% in 2022, then skyrocketed by 33bps to 0.07% in 2023, then tumbled by -173bps to 0.05% in 2024, then skyrocketed by 83bps to 0.01% in 2025.
  • Its last three reported values are 0.01% in Q4 2025, 0.01% for Q3 2025, and 0.01% during Q2 2025.